Alex Wong is an Associate at F-Prime Capital and works across the healthcare sub-sectors including Therapeutics, MedTech, and Healthcare IT and Services, and also closely with the Eight Roads Ventures China team to manage F-Prime’s existing and new investment efforts in China. Prior to F-Prime, Alex was a healthcare strategy consultant with Analysis Group, where he advised biotech and pharmaceutical companies on value proposition strategy, pricing/market access, and health economics/outcomes research.

Alex received his B.A. in Biology and Economics from the University of Pennsylvania.

  • OriGynMED is a developer of medical devices designed for women’s health. The company is mainly engaged in developing various gynecology medical devices such as hysterectomy cold knife and functional hysteroscope, enabling client to improve treatment effect. Learn more at www.origynmed.com.

    • Category

      • MedTech
    • Status

      • Private
    • Location

      Hangzhou, China

    • Year Invested


    • Team

  • Silexon is an emerging AI-empowered technology company which aims to create an open AI platform for strategic collaboration in order to facilitate data-driven life science research and empower drug R&D process, and ultimately provide patients with greater access to innovative drugs for unmet medical needs.  Learn more at www.silexon.tech.